Getinge AB (publ) (GETI-B.ST) Stock Analysis & Winston Score
Getinge is a Swedish medical technology company that makes equipment used in hospitals and life science labs. Its main products include sterilization systems, surgical tables and lights, ventilators, heart-lung machines, and intensive care equipment. Hospitals, clinics, and pharmaceutical manufacturers around the world are its primary customers. The company earns revenue by selling capital equipment and then generating recurring income from consumables, service contracts, and software tied to that installed base. Getinge operates globally, with strong presence in Europe and North America, and reported roughly 34 billion Swedish kronor in annual sales. Its competitive position rests on long-standing customer relationships and the high cost of switching out critical hospital infrastructure once installed. The key risk facing the business is its ongoing effort to resolve past quality and regulatory issues with the U.S. Food and Drug Administration, which previously restricted some product shipments and continues to require close attention to manufacturing compliance.
Winston Score: 62/100 — Good
A decent business — some strong pillars, some weaker.
- Quality: Mixed (11/30)
- Growth: Strong (15/20)
- Cash Flow: Strong (8/10)
- Stability: Strong (7/10)
- Valuation: Strong (7/10)
- Ownership: Good (10/15)
Key Facts
Price: $196.25
Market Cap: $53.5B
Sector: Healthcare
Industry: Medical - Devices
Exchange: Stockholm Stock Exchange


